1. From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School — both in Boston (K.N.V., J.A., A.S.K.); and the Institute of Law, University of Zurich, Zurich, Switzerland (K.N.V.).